Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 22;72(51):1377-1382.
doi: 10.15585/mmwr.mm7251a4.

Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023

Carla L Black, Jennifer L Kriss, Hilda Razzaghi, Suchita A Patel, Tammy A Santibanez, Mehreen Meghani, Ashley Tippins, Shannon Stokley, Kevin Chatham-Stephens, Nicole F Dowling, Georgina Peacock, James A Singleton

Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023

Carla L Black et al. MMWR Morb Mortal Wkly Rep. .

Abstract

During the 2023-24 respiratory virus season, the Advisory Committee on Immunization Practices recommends influenza and COVID-19 vaccines for all persons aged ≥6 months, and respiratory syncytial virus (RSV) vaccine is recommended for persons aged ≥60 years (using shared clinical decision-making), and for pregnant persons. Data from the National Immunization Survey-Adult COVID Module, a random-digit-dialed cellular telephone survey of U.S. adults aged ≥18 years, are used to monitor influenza, COVID-19, and RSV vaccination coverage. By December 9, 2023, an estimated 42.2% and 18.3% of adults aged ≥18 years reported receiving an influenza and updated 2023-2024 COVID-19 vaccine, respectively; 17.0% of adults aged ≥60 years had received RSV vaccine. Coverage varied by demographic characteristics. Overall, approximately 27% and 41% of adults aged ≥18 years and 53% of adults aged ≥60 years reported that they definitely or probably will be vaccinated or were unsure whether they would be vaccinated against influenza, COVID-19, and RSV, respectively. Strong provider recommendations for and offers of vaccination could increase influenza, COVID-19, and RSV vaccination coverage. Immunization programs and vaccination partners are encouraged to use these data to understand vaccination patterns and attitudes toward vaccination in their jurisdictions to guide planning, implementation, strengthening, and evaluation of vaccination activities.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Weekly influenza (A), updated COVID-19 (B), and respiratory syncytial virus (C) vaccination status and vaccination intent among adults — National Immunization Survey-Adult COVID Module, United States, September 24–December 9, 2023 Abbreviation: RSV = respiratory syncytial virus. * Estimates of vaccination coverage were calculated for December 3–9, 2023 using a nondecreasing composite estimation procedure that uses data from all completed interviews during September 24–December 9, 2023: influenza (168,899), COVID-19 (168,669), and RSV (62,816). † Estimates for vaccination intent are based on interviews conducted during December 3–9, 2023, and were adjusted to the cumulative vaccination coverage estimate for that week: influenza (14,562), COVID-19 (14,539), and RSV (5,258). Estimates for vaccination intent are not shown for groups with sample size <30. § Estimates for influenza and COVID-19 vaccination coverage and vaccination intent are among adults aged ≥18 years. Estimates for RSV vaccination coverage and intent are among adults aged ≥60 years.
FIGURE 2
FIGURE 2
Influenza (A), updated COVID-19 (B), and respiratory syncytial virus (C) vaccination status and vaccination intent among adults, by demographic characteristics — National Immunization Survey-Adult COVID Module, United States, December 3–9, 2023 Abbreviations: AI/AN = American Indian or Alaska Native; NH/OPI = Native Hawaiian or other Pacific Islander; RSV = respiratory syncytial virus. * Estimates of vaccination coverage were calculated for December 3–9, 2023 using a nondecreasing composite estimation procedure that uses data from all completed interviews during September 24–December 9, 2023: influenza (168,899), COVID-19 (168,669), and RSV (62,816). † Estimates for vaccination intent are based on interviews conducted during December 3–9, 2023, and were adjusted to the cumulative vaccination coverage estimate for that week: influenza (14,562), COVID-19 (14,539), and RSV (5,258). Estimates for vaccination intent are not shown for groups with sample size <30. § Estimates for influenza and COVID-19 vaccination coverage and vaccination intent are among adults aged ≥18 years. Estimates for RSV vaccination coverage and intent are among adults aged ≥60 years. Persons of Hispanic or Latino (Hispanic) origin might be of any race but are categorized as Hispanic; all racial groups are non-Hispanic.
See this image and copyright information in PMC

References

    1. Grohskopf LA, Blanton LH, Ferdinands JM, et al.. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 influenza season. MMWR Recomm Rep 2023;72(No. RR-1):1–25. 10.15585/mmwr.rr7202a1 - DOI - PMC - PubMed
    1. Regan JJ, Moulia DL, Link-Gelles R, et al. Use of updated COVID-19 vaccines 2023–2024 formula for persons aged ≥6 months: recommendations of the Advisory Committee on Immunization Practices—United States, September 2023. MMWR Morb Mortal Wkly Rep 2023;72:1140–6. 10.15585/mmwr.mm7242e1 - DOI - PMC - PubMed
    1. Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:793–801. 10.15585/mmwr.mm7229a4 - DOI - PMC - PubMed
    1. Black CL, O’Halloran A, Hung MC, et al.; Influenza-Associated Hospitalization Surveillance Network. Vital signs: influenza hospitalizations and vaccination coverage by race and ethnicity—United States, 2009–10 through 2021–22 influenza seasons. MMWR Morb Mortal Wkly Rep 2022;71:1366–73. 10.15585/mmwr.mm7143e1 - DOI - PMC - PubMed
    1. Copeland KR, Ganesh N, Liu L, Santibanez TA, Singleton JA. Statistical improvements in weekly-updated cumulative estimates of flu vaccination coverage for children in the United States. In: Proceedings of the Survey Research Methods Section, American Statistical Association, August 8–12, 2021. http://www.asasrms.org/Proceedings/y2021/files/1912282.pdf